TETRA Technologies, Inc. (TTI) Q2 2025 Earnings Call Transcript

TETRA Technologies (TTI) reported a strong Q2 2025, with adjusted EBITDA of $35.9 million and $37.4 million in base business free cash flow, contributing to a record H1 2025 adjusted EBITDA of $68.1 million, exceeding guidance. This performance was driven by robust deepwater activity and strong industrial chemicals sales, despite a declining U.S. rig count. The company is advancing strategic growth initiatives, including the Arkansas bromine processing facility, expected online by 2027 with significant revenue and EBITDA potential, and its Oasis TDS water desalination technology, which recorded its first revenue and is progressing toward a 25,000 bpd commercial plant design. TTI projects full-year 2025 adjusted EBITDA of $100-$110 million and revenue of $610-$630 million, maintaining a strong balance sheet with 1.2x net leverage, and anticipates material contributions from deepwater contracts and Eos electrolyte deliveries in 2026.

Analysis

TETRA Technologies reported an exceptionally strong first half of 2025, with a record $68.1 million in adjusted EBITDA, surpassing its own guidance. This performance was anchored by robust deepwater activity in its Completion Fluids & Products segment, which saw a 100-basis-point sequential margin increase to 36.7% and is on track for a 10-year revenue high in 2025. This strength successfully counteracted the secular decline in the U.S. land market, where the Water & Flowback segment still outperformed declining frac activity and would have maintained flat margins if not for $2 million in non-recurring costs. The company is methodically executing on several high-impact growth initiatives. A material revenue ramp is anticipated in 2026 from zinc bromide electrolyte sales to Eos Energy, which is expected to complete its automated production line in Q4 2025. To meet this and deepwater demand, TETRA's Arkansas bromine facility project is on track for 2027 completion, projected to add $200-$250 million in revenue and $90-$115 million in adjusted EBITDA annually. Concurrently, its Oasis water desalination technology has booked its first revenue and is advancing with a design for a 25,000 bpd commercial plant, supported by favorable regulatory tailwinds. The company's financial discipline is notable, with strong free cash flow ($53 million in H1) funding growth projects while improving the net leverage ratio to 1.2x, underscoring a commitment to non-dilutive financing.

Key Decisions for Investors

• Investors should assess the company's valuation based on its robust core business, which is generating significant free cash flow ($37.4 million in Q2) and strengthening the balance sheet, providing a solid foundation independent of future growth projects.
• The primary near-term catalyst is the anticipated material ramp-up in electrolyte sales to Eos Energy in 2026; monitor Eos's progress on its automated production line completion in Q4 2025 as a key execution milestone.
• Track the commercialization of the Oasis water desalination technology, as the completion of a commercial plant design in Q4 2025 could precede customer licensing agreements, unlocking a significant long-term growth vector.
• Note management's explicit commitment to non-dilutive financing for the high-impact Arkansas bromine facility, which mitigates shareholder risk; look to the September 25 Investor Day for further details on this strategy and long-term capital return plans.